These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37797257)

  • 1. Continued mitigation needed to minimise the high health burden from COVID-19 in Aotearoa New Zealand.
    Baker MG; Kvalsvig A; Plank MJ; Geoghegan JL; Wall T; Tukuitonga C; Summers J; Bennett J; Kerr J; Turner N; Roberts S; Ward K; Betty B; Huang QS; French N; Wilson N
    N Z Med J; 2023 Oct; 136(1583):67-91. PubMed ID: 37797257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the impact of COVID-19 on Māori:non-Māori health inequities in Aotearoa, New Zealand: an observational study protocol.
    Curtis E; Jaung R; Paine SJ; McLeod M; Tamatea J; Atkinson J; Jiang Y; Robson B; Reid P; Harris RB
    BMJ Open; 2024 Mar; 14(3):e083564. PubMed ID: 38458794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of Covid-19 vaccination in Aotearoa New Zealand: A modelling study.
    Datta S; Vattiato G; Maclaren OJ; Hua N; Sporle A; Plank MJ
    Vaccine; 2024 Feb; 42(6):1383-1391. PubMed ID: 38307744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the impact of the COVID-19 pandemic on perceptions of national scheduled childhood vaccines among Māori and Pacific caregivers, whānau, and healthcare professionals in Aotearoa New Zealand.
    Charania NA; Tonumaipe'a D; Barbarich-Unasa TW; Iusitini L; Davis G; Pacheco G; Wilson D
    Hum Vaccin Immunother; 2024 Dec; 20(1):2301626. PubMed ID: 38205779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cohort profile: Ngā Kawekawe o Mate Korona | Impacts of COVID-19 in Aotearoa - a prospective, national cohort study of people with COVID-19 in New Zealand.
    Russell L; Jeffreys M; Churchward M; Cumming J; McKenzie F; O'Loughlin C; Asiasiga L; Bell R; Hickey H; Irurzun-Lopez M; Kamau L; Kokaua J; McDonald J; McFarland-Tautau M; Smiler K; Uia T; Vaka S; Veukiso-Ulugia A; Wong C; Ellison Loschmann L
    BMJ Open; 2023 Jul; 13(7):e071083. PubMed ID: 37429685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inequities in COVID-19 Omicron infections and hospitalisations for Māori and Pacific people in Te Manawa Taki Midland region, New Zealand.
    Whitehead J; Gan H; Heerikhuisen J; Gray G; Richardson T; Brown P; Lawrenson R
    Epidemiol Infect; 2023 Apr; 151():e74. PubMed ID: 37092681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 in New Zealand and the impact of the national response: a descriptive epidemiological study.
    Jefferies S; French N; Gilkison C; Graham G; Hope V; Marshall J; McElnay C; McNeill A; Muellner P; Paine S; Prasad N; Scott J; Sherwood J; Yang L; Priest P
    Lancet Public Health; 2020 Nov; 5(11):e612-e623. PubMed ID: 33065023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Burden and Temporal Pattern of Hospitalisations Associated With Respiratory Syncytial Virus (RSV) Before and After COVID-19 in New Zealand.
    Turner N; Aminisani N; Huang S; O'Donnell J; Trenholme A; Broderick D; Paynter J; Castelino L; Grant C; McIntyre P
    Influenza Other Respir Viruses; 2024 Jul; 18(7):e13346. PubMed ID: 38980967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the first wave of COVID-19 on the health and psychosocial well-being of Māori, Pacific Peoples and New Zealand Europeans living in aged residential care.
    Cheung G; Bala S; Lyndon M; Ma'u E; Rivera Rodriguez C; Waters DL; Jamieson H; Nada-Raja S; Chan AHY; Beyene K; Meehan B; Walker X
    Australas J Ageing; 2022 Jun; 41(2):293-300. PubMed ID: 34855238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 outbreaks in Aotearoa New Zealand: urgent action is required to address systematic causes and consequences of border failures.
    Kvalsvig A; Summers J; Gray L; Telfar-Barnard L; Baker MG
    N Z Med J; 2020 Dec; 133(1527):8-14. PubMed ID: 33332324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The next phase in Aotearoa New Zealand's COVID-19 response: a tight suppression strategy may be the best option.
    Baker MG; Kvalsvig A; Crengle S; Harwood M; Tukuitonga C; Betty B; Bonning J; Wilson N
    N Z Med J; 2021 Nov; 134(1546):8-16. PubMed ID: 34855729
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploring the depth and breadth of the genomics toolbox during the COVID-19 pandemic: insights from Aotearoa New Zealand.
    Bunce M; Geoghegan JL; Winter D; de Ligt J; Wiles S
    BMC Med; 2023 Jun; 21(1):213. PubMed ID: 37316857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enrolment gap and the COVID-19 pandemic: an exploration of routinely collected primary care enrolment data from 2016 to 2023 in Aotearoa New Zealand.
    Pledger M; Mohan N; Silwal P; Irurzun-Lopez M
    J Prim Health Care; 2023 Dec; 15(4):316-323. PubMed ID: 38112703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2022 restructure of Aotearoa New Zealand's health system: Will it succeed in advancing equity where others have failed?
    Tenbensel T; Cumming J; Willing E
    Health Policy; 2023 Aug; 134():104828. PubMed ID: 37263868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapting an equity-focused implementation process framework with a focus on ethnic health inequities in the Aotearoa New Zealand context.
    Gustafson P; Lambert M; Bartholomew K; Ratima M; Aziz YA; Kremer L; Fusheini A; Carswell P; Brown R; Priest P; Crengle S
    Int J Equity Health; 2024 Jan; 23(1):15. PubMed ID: 38280997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innovative Indigenous-led model for integrated COVID-19 case management in Auckland, New Zealand: lessons from implementation.
    Curtis E; Loring B; Latham K; Jordan A; Chee N; Hunia R; Snowden K; Tari K; Murupaenga P; Tipene R; Whitcombe S; Embers K; McKree Jansen R
    Front Public Health; 2024; 12():1324239. PubMed ID: 38406495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural discrimination in the COVID-19 vaccination programme for people with mental health and addiction issues: now is the time to be equally well.
    Every-Palmer S; Koning A; Smith L; Cunningham R; Lacey C; Peterson D; Jury A; Scott KM; Dowell T; Lockett H
    N Z Med J; 2022 Feb; 135(1550):133-139. PubMed ID: 35728158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Will access to COVID-19 vaccine in Aotearoa be equitable for priority populations?
    Whitehead J; Scott N; Carr PA; Lawrenson R
    N Z Med J; 2021 May; 134(1535):25-35. PubMed ID: 34012138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of COVID-19 on the Health Response to Family Violence in Aotearoa New Zealand: A Qualitative Study.
    Koziol-McLain J; Cowley C; Nayar S; Koti D
    Inquiry; 2023; 60():469580221146832. PubMed ID: 36710509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A tangata whenua (people of the land) approach to conceptualising Māori health and wellbeing.
    Reweti A; Ware F; Moriarty H
    Glob Health Promot; 2023 Jun; 30(2):11-18. PubMed ID: 36314287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.